Aquaculture Pharmaceuticals Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Aquaculture Pharmaceuticals Market: By Product type (Biologics, Parasiticides, Anti-infectives, Reproduction, and Others), Species (Carps, Salmon, Tilapia, Shrimp, Catfish, Trout, and Others) and Geography 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

The Aquaculture pharmaceuticals market valued at 810 Mn in 2021 and expected to reach USD 1343.83 Mn by 2028, at a CAGR of 7.5% during the forecast period 2022 to 2028. Aquaculture Pharmaceuticals market report gives comprehensive outlook on aquaculture pharmaceuticals across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Aquaculture Pharmaceuticals market report includes recent product launches, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analysed market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers engaged in manufacturing and supply of aquaculture pharmaceuticals. Aquaculture industry suffered from many microbial outbreaks that resulted death of many aquatic animals. Lack of drugs/vaccines to new diseases are projected to hamper the growth of the aquaculture pharmaceuticals. Furthermore, antibiotic resistance to the aquatic animals is one of the factors that restraining the growth of market. In the specialised fields of aquaculture feed and medicines, there is an increasing demand for structured R&D, with biologics research being a critical component of R&D projects. This has sped up the introduction of medications, medicated feed, and vaccines into regional markets, particularly in affluent countries like the United States and Canada. Strategic partner selection for M&A initiatives among key companies has supported inorganic growth in the global aquaculture feed and pharmaceutical market.

Aquaculture Pharmaceuticals Market

MARKET SUMMARY
-
7.5% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 7.5%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– Europe

Aquaculture Pharmaceuticals Market

  • The report on global Aquaculture Pharmaceuticals Market gives historical, current, and future market sizes (US$ Mn) on the basis of type of product, species and geography.
  • Aquaculture Pharmaceuticals Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa
Key Players
  • Elanco (Eli Lilly and Company) (U.S.)
  • Intervet Inc., (Merck & Co., Inc.,) (U.S.)
  • Bayer AG (Germany)
  • PharmaQ AS (Zoetis, Inc.,)
Aquaculture Pharmaceuticals Market Dynamics

Pharmaceuticals plays a pivotal role in aquaculture to prevent and treat aquatic animals from various microbial infections. Companies are betting heavily on research and development programs to develop novel drugs that can treat new infections in aquatic animals. For instance, in 2015, PHARMAQ, a part of Zoetis, Inc., invested in to produce fish vaccines in new facility at Klofta. Furthermore, lack of generic drugs to compete with inventor drugs makes more lucrative for the aquaculture pharmaceuticals manufacturers. In addition, global increase in farmed fish production than the wild catch are projected to boost aquaculture pharmaceuticals market over the forecast period. According to Food and Agriculture Organisation of the United Nations (FAO) estimates, the farmed fish production increased by 5.6% from 66.5 Mn tonnes (2013) to 70.2 Mn tonnes (2013).


Asia-Pacific Got Significant Share

Aquaculture Pharmaceuticals Market

Asia-Pacific market dominates the aquaculture pharmaceuticals owing to increase in aquaculture production. As per the Food and Agriculture Organisation of the United Nations (FAO) estimates, China is the largest contributor for aquaculture production. It accounts more than 70% of the world’s total production. India, Vietnam, Thailand and Other ASEAN countries are also responsible for the growth of aquaculture pharmaceuticals market in Asia-Pacific region. In Europe, Norway is the key market for the aquaculture pharmaceuticals market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Aquaculture Pharmaceuticals Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The aquaculture pharmaceuticals market is projected to expand at a CAGR of 7.5% during the forecast period

 

Elanco (Eli Lilly and Company) (U.S), Intervet Inc., (Merck & Co., Inc.,) (U.S.), Bayer AG (Germany), PharmaQ AS (Zoetis, Inc

North America is the fastest-growing region for aquaculture pharmaceuticals market


Report

Table Of Content


Report

Company Profile

  • Elanco (Eli Lilly and Company) (U.S.)
  • Intervet Inc., (Merck & Co., Inc.,) (U.S.)
  • Bayer AG (Germany)
  • PharmaQ AS (Zoetis, Inc.,)

Description

The Aquaculture pharmaceuticals market valued at 810 Mn in 2021 and expected to reach USD 1343.83 Mn by 2028, at a CAGR of 7.5% during the forecast period 2022 to 2028. Aquaculture Pharmaceuticals market report gives comprehensive outlook on aquaculture pharmaceuticals across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, Aquaculture Pharmaceuticals market report includes recent product launches, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analysed market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers engaged in manufacturing and supply of aquaculture pharmaceuticals. Aquaculture industry suffered from many microbial outbreaks that resulted death of many aquatic animals. Lack of drugs/vaccines to new diseases are projected to hamper the growth of the aquaculture pharmaceuticals. Furthermore, antibiotic resistance to the aquatic animals is one of the factors that restraining the growth of market. In the specialised fields of aquaculture feed and medicines, there is an increasing demand for structured R&D, with biologics research being a critical component of R&D projects. This has sped up the introduction of medications, medicated feed, and vaccines into regional markets, particularly in affluent countries like the United States and Canada. Strategic partner selection for M&A initiatives among key companies has supported inorganic growth in the global aquaculture feed and pharmaceutical market.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX